Literature DB >> 25476985

Comments on Cecconi et al.: consensus on circulatory shock and hemodynamic monitoring. task force of the European Society of Intensive Care Medicine.

Daniel Eduardo Agudelo Torres1, Jose Navarro-Martinez, Maria Galiana-Ivars, Carmelo Alarcon Martinez.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25476985     DOI: 10.1007/s00134-014-3588-x

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

1.  Femoral-radial arterial pressure gradients in critically ill patients.

Authors:  Steven T Galluccio; Marianne J Chapman; Mark E Finnis
Journal:  Crit Care Resusc       Date:  2009-03       Impact factor: 2.159

2.  Radial artery pressure monitoring underestimates central arterial pressure during vasopressor therapy in critically ill surgical patients.

Authors:  T Dorman; M J Breslow; P A Lipsett; J M Rosenberg; J R Balser; Y Almog; B A Rosenfeld
Journal:  Crit Care Med       Date:  1998-10       Impact factor: 7.598

3.  Radial to femoral arterial blood pressure differences in septic shock patients receiving high-dose norepinephrine therapy.

Authors:  Won Young Kim; Jong Hun Jun; Jin Won Huh; Sang Bum Hong; Chae-Man Lim; Younsuck Koh
Journal:  Shock       Date:  2013-12       Impact factor: 3.454

4.  Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine.

Authors:  Maurizio Cecconi; Daniel De Backer; Massimo Antonelli; Richard Beale; Jan Bakker; Christoph Hofer; Roman Jaeschke; Alexandre Mebazaa; Michael R Pinsky; Jean Louis Teboul; Jean Louis Vincent; Andrew Rhodes
Journal:  Intensive Care Med       Date:  2014-11-13       Impact factor: 17.440

Review 5.  Clinical review: complications and risk factors of peripheral arterial catheters used for haemodynamic monitoring in anaesthesia and intensive care medicine.

Authors:  Bernd Scheer; Azriel Perel; Ulrich J Pfeiffer
Journal:  Crit Care       Date:  2002-04-18       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.